Clinical trial Recruiting at 2 sites Interventional Ages 18 to 65

Repetitive TMS to relieve neuropathic pain after spinal cord injury

Official title: The Effect of Transcranial Magnetic Stimulation Applied to the Primary Motor Cortex and Anterior Cingulate Cortex on Refractory Neuropathic Pain in Spinal Cord Injury

Run by Ankara Etlik City Hospital · NCT07293780 · Data updated 2026-11-12

This trial will test whether rTMS aimed at the anterior cingulate cortex reduces chronic neuropathic pain in adults with spinal cord injury compared with motor cortex stimulation or a sham treatment.

More Spinal Cord Injury trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment39 (estimated)
SponsorAnkara Etlik City Hospital
Government
Locations2 sites (Ankara, Yenimahalle and 1 other locations)
StatusRecruiting
StartedDecember 15, 2025
Main results expectedMay 1, 2027
Study endsAugust 1, 2027
Registry record updatedNovember 2, 2026
Trial IDNCT07293780 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 who are at least 12 months post–spinal cord injury, have central neuropathic pain below the lesion for ≥6 months with VAS > 4 despite medications and therapy, and meet safety criteria for TMS.

Probably not a fit

Patients with a history of epilepsy, metallic or electronic cranial implants, spinal cord stimulators, pacemakers, significant psychiatric illness, pregnancy, or pain attributable to other causes (e.g., diabetes, rheumatologic disease) are unlikely to benefit or are ineligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with chronic central neuropathic pain after spinal cord injury will receive repetitive transcranial magnetic stimulation (rTMS) targeted to the anterior cingulate cortex, compared with motor cortex stimulation and sham TMS. The intervention arms include active and sham TMS; treatments are delivered in person at participating hospitals. Eligible participants are 18–65 years old, at least 12 months post-injury, with pain below the lesion for at least 6 months and VAS > 4 despite standard pharmacologic and rehabilitative care. Exclusions include epilepsy, metallic or electronic cranial implants, spinal cord stimulator, pacemaker, significant psychiatric illness, and pregnancy; pain due to other causes is also excluded.

Why it matters

Potential benefit: If successful, the intervention could reduce chronic neuropathic pain and improve daily function and quality of life for people with spinal cord injury.

How similar studies have gone: Previous studies of motor cortex rTMS have shown modest benefits for neuropathic pain, while anterior cingulate targeting is a more novel approach with limited prior testing.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients for whom at least 12 months have passed since the date of the spinal cord injury
2. Patients who meet the International Spinal Cord Injury Pain (ISCIP) Classification criteria for central neuropathic pain below the level of the lesion and who have had pain for at least 6 months
3. Patients aged 18-65
4. Pain not attributable to other causes such as rheumatological diseases or diabetes
5. Patients with VAS \> 4 despite maximum dose of pharmacological agents (anticonvulsants, antidepressants, opioids), exercise and physical therapy agents, taking into account renal function tests and other comorbidities

Exclusion Criteria:

1. History of epilepsy
2. Metallic implant in the scalp
3. Cochlear implant
4. Spinal cord stimulator
5. Pacemaker
6. Presence of psychiatric illness
7. Pregnancy

Where it's running

  • Ankara Etlik City Hospital
    Ankara, Yenimahalle, Turkey (Türkiye)
    Recruiting
  • Gaziler Physical Therapy and Rehabilitation Training and Research Hospital
    Ankara, Çankaya, Turkey (Türkiye)
    Recruiting

Study contacts

  • Principal investigator: Ayşe Naz Kalem, Specialist — Ankara Etlik City Hospital
  • Study coordinator: Ayşe Naz Kalem Özgen, specialist
  • Email: kalemnaz@gmail.com
  • Phone: +90 312 797 00 00

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.